← back to search

Karli Hedstrom

University of Miami · US
Area of research
Molecular Biology · Rheumatology
Research interest
Research interests include Folate and B Vitamins Research, Porphyrin Metabolism and Disorders, Health Systems, Economic Evaluations, Quality of Life, and Pharmaceutical Economics and Policy.
h-index
2
citations
61
works
3
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Evidence-based consensus guidelines for the diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and X-linked protoporphyria
Hepatology 2023cited by 20position: middledoi
Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria
Journal of the American Academy of Dermatology 2022cited by 39position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Haya S. Raef · Tufts University2 papers (2022–2023)Mohamed Kazamel · University of Alabama at Birmingham2 papers (2022–2023)Sioḃán Keel · University of Washington2 papers (2022–2023)Hetanshi Naik · Stanford Medicine2 papers (2022–2023)Bruce Wang · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2022–2023)Behnam Saberi · Harvard University2 papers (2022–2023)Manisha Balwani · University of Miami2 papers (2022–2023)Rebecca Karp Leaf · Boston University2 papers (2022–2023)Sean Rudnick · Wake Forest University2 papers (2022–2023)— · 2 papers (2022–2023)Sarina B. Elmariah · University of California, San Francisco2 papers (2022–2023)Robert J. Goddu · Massachusetts General Hospital2 papers (2022–2023)Angelika Erwin · Cleveland Clinic2 papers (2022–2023)Cynthia Levy · University of Miami2 papers (2022–2023)Manish Thapar · Drexel University2 papers (2022–2023)John G. Quigley · Illinois College2 papers (2022–2023)Marshall Mazepa · University of Minnesota2 papers (2022–2023)Simon W. Beaven · University of California, Los Angeles2 papers (2022–2023)Jonathan Ungar · University of Connecticut2 papers (2022–2023)Karl E. Anderson · Moderna Therapeutics (United States)1 papers (2023–2023)